About
Technology
Issues
FAQ
Links
Official Page
Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.